Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development

Gastric carcinoma (GC) is the 2nd most common cause of cancer-related death. Despite advances in conventional treatment and surgical interventions, a high percentage of GC patients still have poor survival. Recently, immunotherapy has become a promising approach to treat GC. Here, we present preclin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abozeid, Mohamed, Rosato, Antonio, Sommaggio, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525095/
https://www.ncbi.nlm.nih.gov/pubmed/28781967
http://dx.doi.org/10.1155/2017/5791262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525095/
https://www.ncbi.nlm.nih.gov/pubmed/28781967
http://dx.doi.org/10.1155/2017/5791262

Ejemplares similares